NTRA
Price
$153.19
Change
+$2.10 (+1.39%)
Updated
May 23, 04:59 PM (EDT)
Capitalization
11.04B
69 days until earnings call
SMTI
Price
$30.23
Change
-$0.78 (-2.51%)
Updated
May 23, 04:59 PM (EDT)
Capitalization
319.04M
87 days until earnings call
Interact to see
Advertisement

NTRA vs SMTI

Header iconNTRA vs SMTI Comparison
Open Charts NTRA vs SMTIBanner chart's image
Natera
Price$153.19
Change+$2.10 (+1.39%)
Volume$15.07K
Capitalization11.04B
Sanara MedTech
Price$30.23
Change-$0.78 (-2.51%)
Volume$1K
Capitalization319.04M
NTRA vs SMTI Comparison Chart
Loading...
NTRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SMTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NTRA vs. SMTI commentary
May 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTRA is a Hold and SMTI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 24, 2025
Stock price -- (NTRA: $151.09 vs. SMTI: $31.02)
Brand notoriety: NTRA and SMTI are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NTRA: 0% vs. SMTI: 63%
Market capitalization -- NTRA: $11.04B vs. SMTI: $319.04M
NTRA [@Medical Specialties] is valued at $11.04B. SMTI’s [@Medical Specialties] market capitalization is $319.04M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NTRA’s FA Score shows that 0 FA rating(s) are green whileSMTI’s FA Score has 0 green FA rating(s).

  • NTRA’s FA Score: 0 green, 5 red.
  • SMTI’s FA Score: 0 green, 5 red.
According to our system of comparison, NTRA is a better buy in the long-term than SMTI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTRA’s TA Score shows that 5 TA indicator(s) are bullish while SMTI’s TA Score has 3 bullish TA indicator(s).

  • NTRA’s TA Score: 5 bullish, 3 bearish.
  • SMTI’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, NTRA is a better buy in the short-term than SMTI.

Price Growth

NTRA (@Medical Specialties) experienced а +1.13% price change this week, while SMTI (@Medical Specialties) price change was +0.45% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.78%. For the same industry, the average monthly price growth was +5.29%, and the average quarterly price growth was -0.03%.

Reported Earning Dates

NTRA is expected to report earnings on Jul 31, 2025.

SMTI is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Medical Specialties (-0.78% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTRA($11B) has a higher market cap than SMTI($319M). NTRA YTD gains are higher at: -4.555 vs. SMTI (-6.566). SMTI has higher annual earnings (EBITDA): -289.09K vs. NTRA (-397.8M). NTRA has more cash in the bank: 879M vs. SMTI (5.15M). SMTI has less debt than NTRA: SMTI (11.8M) vs NTRA (442M). NTRA has higher revenues than SMTI: NTRA (1.08B) vs SMTI (65M).
NTRASMTINTRA / SMTI
Capitalization11B319M3,448%
EBITDA-397.8M-289.09K137,601%
Gain YTD-4.555-6.56669%
P/E RatioN/AN/A-
Revenue1.08B65M1,666%
Total Cash879M5.15M17,078%
Total Debt442M11.8M3,746%
FUNDAMENTALS RATINGS
NTRA vs SMTI: Fundamental Ratings
NTRA
SMTI
OUTLOOK RATING
1..100
964
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
72
Overvalued
PROFIT vs RISK RATING
1..100
3459
SMR RATING
1..100
9292
PRICE GROWTH RATING
1..100
5158
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NTRA's Valuation (53) in the Biotechnology industry is in the same range as SMTI (72) in the null industry. This means that NTRA’s stock grew similarly to SMTI’s over the last 12 months.

NTRA's Profit vs Risk Rating (34) in the Biotechnology industry is in the same range as SMTI (59) in the null industry. This means that NTRA’s stock grew similarly to SMTI’s over the last 12 months.

NTRA's SMR Rating (92) in the Biotechnology industry is in the same range as SMTI (92) in the null industry. This means that NTRA’s stock grew similarly to SMTI’s over the last 12 months.

NTRA's Price Growth Rating (51) in the Biotechnology industry is in the same range as SMTI (58) in the null industry. This means that NTRA’s stock grew similarly to SMTI’s over the last 12 months.

NTRA's P/E Growth Rating (100) in the Biotechnology industry is in the same range as SMTI (100) in the null industry. This means that NTRA’s stock grew similarly to SMTI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NTRASMTI
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 11 days ago
80%
Declines
ODDS (%)
Bearish Trend 9 days ago
80%
Bearish Trend 2 days ago
77%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
NTRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SMTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MIY11.320.01
+0.09%
Blackrock Muniyield Michigan Quality Fund
CXE3.51N/A
N/A
MFS High Income Municipal Trust
FLLA21.50N/A
N/A
Franklin FTSE Latin America ETF
RODM33.34-0.02
-0.06%
Hartford Multifactor Dev Mkts (exUS) ETF
VGK76.27-0.10
-0.13%
Vanguard FTSE Europe ETF

NTRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTRA has been loosely correlated with ISRG. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if NTRA jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTRA
1D Price
Change %
NTRA100%
N/A
ISRG - NTRA
57%
Loosely correlated
N/A
BSX - NTRA
51%
Loosely correlated
-0.13%
VCYT - NTRA
51%
Loosely correlated
N/A
GKOS - NTRA
48%
Loosely correlated
+2.50%
RDNT - NTRA
48%
Loosely correlated
N/A
More

SMTI and

Correlation & Price change

A.I.dvisor indicates that over the last year, SMTI has been loosely correlated with TRUMY. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if SMTI jumps, then TRUMY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMTI
1D Price
Change %
SMTI100%
N/A
TRUMY - SMTI
44%
Loosely correlated
+1.51%
NTRA - SMTI
44%
Loosely correlated
N/A
IQV - SMTI
43%
Loosely correlated
+0.55%
STXS - SMTI
43%
Loosely correlated
-0.98%
RDNT - SMTI
42%
Loosely correlated
N/A
More